![\"\"](\"https:\/\/www.brandhonchos.co.in\/brandhonchos\/wp-content\/uploads\/2021\/09\/sunpharma-1.jpg\")
<\/p>\n","protected":false},"excerpt":{"rendered":"Pharma tycoon, Dilip Shanghvi, founder of Sun Pharmaceutical Industries, the world\u2019s fourthlargest speciality generics maker and India\u2019s most valuable pharmaceutical company, is one of India\u2019s esteemed self-made billionaires. The mastermind has transformed a small start-up into a multinational conglomerate that ranks as the world\u2019s fourth-largest speciality generics company with an estimated revenue of $4.2 billion in 2019. The massive strides of
\nSun Pharma have hiked Mr. Sanghvi\u2019s net worth to Rs 52,000 crores and positioned India at the apex of the pharma manufacturing sector especially in the generic segment.<\/p>\n
Under the apt leadership of this Padma Shri awardee, Sun Pharma swelled in terms of expansions and acquisitions, tracing one of the most impressive growth graphs in a short span of 30 years. Currently, the biggest player in generic medicines serves as the provider of quality drugs and medicines to over 150 countries. The business magnate bolstered the growth of his business by acquiring more than a dozen companies struggling to stand in the competitive market and then transforming these loss-making pockets into profit earners.<\/p>\n
The brilliant beacon of the Pharma industry has expanded the company\u2019s wing across a range of generic medicines including cardiology, gastroenterology, neurology, ophthalmology and other segments. Apart from his exemplary work in restructuring the Indian pharma manufacturing segment, Mr. Shanghvi is also bolstering the Indian economy by supporting emerging start-ups as a personal investor, with interests spanning across multiple sectors that stretches from renewable energy to the oil and gas segment.<\/p>\n
This investment powerhouse and manufacturing Mogul is truly ahead of the curve in spinning the Indian economy. One of India\u2019s most valuable assets, Sun pharma gets 70% of its revenues from overseas, and the company is geared to accelerate its growth at a scorching pace. Thus, we can say that the country\u2019s economy can safely bet on this winning horse of the big league!<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
The rising Sun of the pharmaceuticals sector! Pharma tycoon, Dilip Shanghvi, founder of Sun Pharmaceutical Industries, the world\u2019s fourthlargest speciality generics maker and India\u2019s most valuable pharmaceutical company, is one of India\u2019s esteemed self-made billionaires. The mastermind has transformed a small start-up into a multinational conglomerate that ranks as the world\u2019s fourth-largest speciality generics company … Continue reading Sun Pharma<\/span>